Defne Garner, CA

Defne is one of the founders of Ripple Therapeutics (RIPL) following its spin out from Interface Biologics (IBI) in 2020. Defne joined IBI in 2013. She leads finance and administration and is a Chartered Professional Accountant, CA (CPA Ontario). Defne held previous roles as Assistant Controller, Latin America, at SAS Institute Inc. and completed her articling for her professional designation at KPMG LLP. Defne holds a MAcc, Master of Accounting (University of Waterloo) and a BSc, Biotechnology/Chartered Accounting (University of Waterloo).